Z11.1

Encounter for screening for respiratory tuberculosis

Encounter for screening for respiratory tuberculosis (Z11.1) is a specialized clinical visit designated for the testing of individuals who are currently asymptomatic but are members of populations at elevated risk for Mycobacterium tuberculosis infection. This encounter is a cornerstone of public health surveillance, aimed at the early detection of latent or subclinical tuberculosis (TB) to prevent progression to active, contagious disease and to limit community transmission. Screening methodologies primarily involve the Tuberculin Skin Test (TST), such as the Mantoux purified protein derivative (PPD) test, or Interferon-Gamma Release Assays (IGRAs), which measure the T-cell immune response to TB-specific antigens. This code is specifically intended for screening purposes and should not be used when an individual presents with active symptoms suggestive of TB or for the routine follow-up of a previously diagnosed and treated case. It is frequently employed in pre-employment evaluations, immigration health assessments, and post-exposure contact investigations.

Clinical Symptoms

Chronic cough lasting more than three weeks
Hemoptysis (expectoration of blood)
Unexplained weight loss
Nocturnal hyperhidrosis (night sweats)
Low-grade pyrexia (fever)
Pleuritic chest pain
Persistent fatigue or malaise
Anorexia
Lymphadenopathy
History of close contact with active pulmonary tuberculosis cases
Recent travel to or residence in endemic regions

Common Causes

Infection with Mycobacterium tuberculosis complex
Exposure to aerosolized droplets from an individual with active pulmonary TB
Living or working in high-density congregate settings such as correctional facilities or shelters
Employment in healthcare environments with high TB prevalence
Immunocompromised status due to HIV/AIDS
Chronic use of immunosuppressive medications (e.g., TNF-alpha inhibitors)
Substance abuse and malnutrition
Immigration from geographic areas with high TB burden

Documentation & Coding Tips

Distinguish Screening from Exposure Documentation

Example: Patient presents for administrative screening required for nursing school enrollment. Patient denies cough, night sweats, or weight loss. No known history of contact with active tuberculosis cases. Documentation of the screening intent without symptoms supports the use of Z11.1 for routine surveillance. Billing Focus: Intent of encounter. Risk Adjustment: Distinguishes preventative screening from active diagnostic investigation.

Billing Focus: Intent of encounter (Screening vs. Diagnostic)

Specify the Testing Modality in the Note

Example: Planned administration of Tuberculin Purified Protein Derivative (PPD) via Mantoux technique (5 TU) for annual employment screening. Patient has no history of BCG vaccination or prior positive tests. Billing Focus: Supports CPT 86580. Risk Adjustment: Documents the baseline for future clinical comparison.

Billing Focus: Method of screening (TST vs. IGRA)

Clarify Asymptomatic Status

Example: Patient is currently asymptomatic with no pulmonary complaints. Screening is performed due to recent immigration from a high-prevalence region. No current comorbidities such as HIV or immunosuppression noted. Billing Focus: Exclusion of symptomatic codes (R05.9, R06.0). Risk Adjustment: Confirms the patient is a healthy screener rather than an acute case.

Billing Focus: Absence of respiratory symptoms

Incorporate Occupational Risk Factors

Example: Annual respiratory tuberculosis screening for a correctional facility officer. Patient reports no contact with known active cases in the last 12 months. Lungs are clear to auscultation. Billing Focus: Justification for medical necessity in workplace health. Risk Adjustment: Identifies social determinants and environmental risk factors.

Billing Focus: Occupational necessity

Document Post-Screening Follow-up Requirements

Example: Patient advised to return in 48 to 72 hours for TST reading. Instructions provided on site care. Patient understands that if the result is positive, a chest X-ray and clinical evaluation for latent vs. active TB will follow. Billing Focus: Continuity of the screening episode. Risk Adjustment: Prepares documentation for potential transition to latent TB (Z22.7) coding.

Billing Focus: Plan for result interpretation

Relevant CPT Codes

86580 - Tuberculosis intradermal test
Primary procedure code for the administration of a TST during a screening encounter.
86480 - TB test, cell mediated immunity antigen response, gamma interferon
Standard blood test used for TB screening, often preferred in BCG-vaccinated patients.
99212 - Office outpatient, established, straightforward MDM, 10-19 mins
Appropriate for a brief encounter to read a TST result or discuss a negative IGRA.
99213 - Office outpatient, established, low MDM, 20-29 mins
Used when the screening involves more detailed counseling regarding risk or testing options.
99202 - Office outpatient, new, straightforward MDM, 15-29 mins
Standard for a new patient presenting solely for TB screening purposes.
99203 - Office outpatient, new, low MDM, 30-44 mins
Appropriate for new patients with complex risk factors requiring more extensive screening history.
71045 - Chest X-ray, single view
Secondary screening tool often used if a TST or IGRA is positive.
99000 - Specimen handling
Used for processing IGRA blood samples for external labs.
99401 - Preventive medicine counseling, individual, 15 mins
Used when counseling on TB prevention is the primary focus of the visit.
86481 - TB test, cell mediated immunity, Enumeration of T-cells
An alternative IGRA test used for screening.